1. Home
  2. STAA vs EMBC Comparison

STAA vs EMBC Comparison

Compare STAA & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAA
  • EMBC
  • Stock Information
  • Founded
  • STAA 1982
  • EMBC 1924
  • Country
  • STAA United States
  • EMBC United States
  • Employees
  • STAA N/A
  • EMBC N/A
  • Industry
  • STAA Ophthalmic Goods
  • EMBC Medical/Dental Instruments
  • Sector
  • STAA Health Care
  • EMBC Health Care
  • Exchange
  • STAA Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • STAA 915.7M
  • EMBC 811.2M
  • IPO Year
  • STAA N/A
  • EMBC N/A
  • Fundamental
  • Price
  • STAA $28.37
  • EMBC $13.69
  • Analyst Decision
  • STAA Hold
  • EMBC Buy
  • Analyst Count
  • STAA 8
  • EMBC 2
  • Target Price
  • STAA $22.50
  • EMBC $19.00
  • AVG Volume (30 Days)
  • STAA 3.4M
  • EMBC 737.9K
  • Earning Date
  • STAA 08-06-2025
  • EMBC 08-08-2025
  • Dividend Yield
  • STAA N/A
  • EMBC 4.38%
  • EPS Growth
  • STAA N/A
  • EMBC 18.26
  • EPS
  • STAA N/A
  • EMBC 1.42
  • Revenue
  • STAA $224,449,000.00
  • EMBC $1,102,500,000.00
  • Revenue This Year
  • STAA N/A
  • EMBC N/A
  • Revenue Next Year
  • STAA $26.12
  • EMBC N/A
  • P/E Ratio
  • STAA N/A
  • EMBC $9.63
  • Revenue Growth
  • STAA N/A
  • EMBC N/A
  • 52 Week Low
  • STAA $13.50
  • EMBC $9.20
  • 52 Week High
  • STAA $38.60
  • EMBC $21.48
  • Technical
  • Relative Strength Index (RSI)
  • STAA 83.25
  • EMBC 71.49
  • Support Level
  • STAA $17.20
  • EMBC $9.65
  • Resistance Level
  • STAA $30.81
  • EMBC $14.22
  • Average True Range (ATR)
  • STAA 0.74
  • EMBC 0.57
  • MACD
  • STAA 0.67
  • EMBC 0.38
  • Stochastic Oscillator
  • STAA 82.07
  • EMBC 88.40

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: